Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 17.77M | £ 15.33M | £ 26.27M | £ 23.04M | £ 20.05M |
Total Assets | £ 225.52M | £ 208.34M | £ 225.37M | £ 228.48M | £ 226.69M |
Total Debt | £ 65.60M | £ 56.62M | £ 75.58M | £ 77.66M | £ 78.12M |
Net Debt | £ 47.83M | £ 41.29M | £ 49.31M | £ 54.62M | £ 58.06M |
Total Liabilities | £ 106.18M | £ 89.45M | £ 108.24M | £ 111.91M | £ 113.37M |
Stockholders Equity | £ 119.34M | £ 118.89M | £ 117.13M | £ 116.57M | £ 113.33M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |